SOPH (SOPHiA GENETICS SA) Company Profit

SOPH (SOPHiA GENETICS SA) - company brandmark

The SOPHiA GENETICS SA (SOPH) price chart demonstrates profit dynamics, which currently stand at -0.08. The business relies on cloud AI for genome sequencing, eliminating routine tasks for diagnosticians while maintaining a minimal headcount. Simultaneously, SOPHiA GENETICS SA is implementing the SOPHiA DDM system for oncology marker prediction, ensuring the rapid release of software updates.

SOPH sophiagenetics.com Company Net Income (07/04/2022 - 10/30/2026)

Financial and market metric breakdowns for sophiagenetics.com (SOPH)

- stock value and consensus price forecast:
Market Price SOPHiA GENETICS|SOPH - Analyst Consensus Forecast
- business market valuation indicators:
Market Capitalization SOPH|SOPH - Total Company Value
- book capitalization information:
Net Assets per Share SOPHiA GENETICS SA|SOPH - Company Book Value|Market-to-Book Ratio sophiagenetics.com|SOPH - Aggregate Company Assets
- debt and liquidity details:
Aggregate Debt to Equity SOPHiA GENETICS SA|SOPH - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital SOPHiA GENETICS|SOPH - Company Aggregate Debts|Debts to Net Assets SOPH|SOPH - Company Long-Term Debts|Company Short-Term Debts SOPHiA GENETICS SA|Intermediate Coverage Ratio sophiagenetics.com
- earnings and multiples data:
SOPH - Net Profit
Fundamental valuation:SOPH - SOPHiA GENETICS S.A.
Product sample of Sophia Genetics

Professional managers utilize fundamental filters to screen out illiquid assets. This metric measures the business's net income, adjusted for one-off factors, confirming the issuer's actual financial stability. For SOPHiA GENETICS SA (SOPH), which is scaling its genomic analysis platform in oncology, this indicator reflects the efficiency of technology commercialization. The current value of -0.08 demonstrates monetization dynamics during the growth phase. By analyzing the company's net profit level, an investor can assess the risk of market overheating.

Direct competitors

Company Net Income Veeva Corp (VEEV)|DOCS (Doximity, Inc.) - Net Profit|Company Profit HQY (healthequity.com)|Company Net Income Waystar (WAY)|Net Financial Result CorVel Corp|Company Net Income Privia Health Corp PRVA|Huron Corp (HURN) - Company Net Income|CERT - Company Net Income|Profit After Tax OMCL|GDRX: Net Profit|Schrodinger Inc - Final Profit|PHR (Phreesia Corp) - Net Profit|Omada (OMDA) - Net Financial Result|Net Profit EVH|Net Profit healthstream.com (HSTM)|Definitive Healthcare Corp. - Net Income|Final Profit CCSI|agilon health Inc - Net Profit|Annual Net Income Absci Bio (ABSI)|SY: Net Profit|Company Net Income NRC Health (NRC)|Company Net Income Spok|Company Profit OPRX (OptimizeRx Corp)|Net Profit TBRG|SLP - Company Net Income|Health Catalyst, Inc. - Net Income|Profit After Payment of Taxes CCLD (CareCloud Inc.)|Research Solutions - Net Profit|Net Financial Result DLH Holdings Corp. DLHC|ONMD: Net Profit|Net Income Scienture Corp|Company Net Income Healthcare Triangle|iSpecimen Corp (ISPC) - Net Financial Result|Net Income BFRG (Bullfrog AI Holdings)|WORX (SCWorx Corp) - Final Profit|Company Net Income LifeWallet MSPR|Net Financial Result iCoreConnect, Inc. (ICCT)|TRxADE HEALTH, Inc. - Net Profit|ORGS - Net Profit|r1rcm.com (RCM) - Company Net Income|SHCR - Net Financial Result|Company Net Income Streamline Health Solutions Inc.|Company Net Income Syra Health, Corp. SYRA|Company Net Income Apollo Medical Holdings (AMEH)|MODN: Profit After Tax|Net Profit NXGN (NextGen Healthcare, Inc.)